Bergen, Norway

Lars Herfindal

This inventor holds 1 USPTO granted patent. Top assignees: Bergen Teknologioverføring as, Universitetet I Oslo, University Claude Bernard - Lyon 1. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lars Herfindal. Retrieved from https://idiyas.com/inventor/lars-herfindal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lars Herfindal: Innovator in Anti-Neoplastic and Anti-Infective Agents

Introduction

Lars Herfindal is a notable inventor based in Bergen, Norway. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds with therapeutic applications.

Latest Patents

Herfindal holds a patent for "Phenazine derivatives as anti-neoplastic agents and anti-infective agents." This patent encompasses novel phenazine derivatives, methods for their preparation, and their medical use, specifically as anti-neoplastic and anti-infective agents. Additionally, it includes innovative methods for the preparation of iodinin and myxin.

Career Highlights

Throughout his career, Lars Herfindal has worked with esteemed institutions such as Universitetet i Oslo and Bergen Teknologioverføring AS. His work has focused on advancing the understanding and application of phenazine derivatives in medical treatments.

Collaborations

Some of his notable coworkers include Stein Ove Døskeland and Pål Rongved. Their collaborative efforts have contributed to the development of important research in the field.

Conclusion

Lars Herfindal's innovative work in the realm of anti-neoplastic and anti-infective agents highlights his role as a significant contributor to medicinal chemistry. His patent and collaborations reflect his commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…